Rep. David Taylor Sells Off Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Representative David Taylor (R-Ohio) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on June 02nd, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on May 14th. The trade occurred in the Representative’s “DAVID TAYLOR TRUST > SCHWAB JOINT BROKERAGE #1 (HOME GROWN)” account.

Representative David Taylor also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Installed Building Products (NYSE:IBP) on 5/15/2025.
• Purchased $1,001 – $15,000 in shares of Fifth Third Bancorp (NASDAQ:FITB) on 5/14/2025.
• Purchased $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 5/14/2025.
• Sold $15,001 – $50,000 in shares of UnitedHealth Group (NYSE:UNH) on 5/14/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 5/13/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 5/12/2025.
• Purchased $1,001 – $15,000 in shares of Salesforce (NYSE:CRM) on 5/12/2025.
• Purchased $1,001 – $15,000 in shares of Amazon.com (NASDAQ:AMZN) on 3/27/2025.
• Purchased $1,001 – $15,000 in shares of Parker-Hannifin (NYSE:PH) on 3/10/2025.
• Purchased $1,001 – $15,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 3/10/2025.

UnitedHealth Group Trading Down 1.1%

UNH opened at $301.43 on Wednesday. The firm has a market capitalization of $273.44 billion, a P/E ratio of 19.45, a P/E/G ratio of 1.37 and a beta of 0.56. The firm’s 50 day moving average is $422.31 and its 200-day moving average is $489.42. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 52-week low of $248.88 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same period in the previous year, the company earned $6.91 earnings per share. Analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The stock was purchased at an average cost of $320.80 per share, for a total transaction of $491,786.40. Following the acquisition, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Kristen Gil purchased 3,700 shares of the company’s stock in a transaction dated Thursday, May 15th. The stock was purchased at an average cost of $271.17 per share, for a total transaction of $1,003,329.00. Following the transaction, the director now owns 3,818 shares of the company’s stock, valued at approximately $1,035,327.06. This trade represents a 3,135.59% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired a total of 109,408 shares of company stock worth $31,607,768 in the last 90 days. 0.33% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on UNH. Argus downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Monday, April 21st. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating for the company in a research report on Wednesday, May 14th. Hsbc Global Res downgraded UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Barclays reduced their target price on UnitedHealth Group to $350.00 and set an “overweight” rating on the stock in a report on Monday. Finally, Piper Sandler dropped their price target on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a research report on Tuesday. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and seventeen have assigned a buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $428.43.

Institutional Trading of UnitedHealth Group

Hedge funds have recently made changes to their positions in the stock. Invst LLC lifted its position in UnitedHealth Group by 295.3% in the 1st quarter. Invst LLC now owns 5,491 shares of the healthcare conglomerate’s stock worth $2,876,000 after buying an additional 4,102 shares in the last quarter. Hodges Capital Management Inc. purchased a new stake in shares of UnitedHealth Group during the first quarter worth $210,000. Modern Wealth Management LLC grew its stake in UnitedHealth Group by 3.3% in the first quarter. Modern Wealth Management LLC now owns 6,996 shares of the healthcare conglomerate’s stock valued at $3,664,000 after purchasing an additional 226 shares in the last quarter. Nova Wealth Management Inc. lifted its holdings in shares of UnitedHealth Group by 339.1% during the 1st quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock valued at $53,000 after buying an additional 78 shares during the last quarter. Finally, Jones Financial Companies Lllp raised its position in UnitedHealth Group by 30.1% during the first quarter. Jones Financial Companies Lllp now owns 87,961 shares of the healthcare conglomerate’s stock valued at $45,587,000 after acquiring an additional 20,375 shares in the last quarter. 87.86% of the stock is owned by hedge funds and other institutional investors.

About Representative Taylor

David Taylor (Republican Party) is a member of the U.S. House, representing Ohio’s 2nd Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Taylor (Republican Party) ran for election to the U.S. House to represent Ohio’s 2nd Congressional District. He won in the general election on November 5, 2024.

David Taylor graduated from Amelia High School. Taylor earned degrees from Miami University (Ohio) and the University of Dayton School of Law. Taylor’s career experience includes working as an attorney and as a businessman at Sardinia Ready Mix, Inc.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.